MetaCap

Solid Biosciences Insider Trades

NASDAQ: SLDBHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

6.87+0.05 (+0.73%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
20 · $2.50M
Shares bought / sold
0 / 391.57K
Net activity
Net selling $2.5 million

Solid Biosciences insider activity

Over the last 12 months, Solid Biosciences insiders reported 43 transactions on SEC Form 4: 0 open-market purchases and 20 sales. Insiders bought $0 and sold $2.5 million worth of stock, for net insider selling of $2.5 million. The largest seller was Cumbo Alexander, with $928,628 in reported sales.

The most recent filing shows SMITH IAN F (Director) reporting a transaction in 3,440 shares on Oct 2, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put SLDB's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

SLDB insider transactions

Solid Biosciences insider transactions
DateInsiderTypeSharesValueFiling
Oct 2, 2026SMITH IAN FDirectorOption exercise3,440—Form 4
Jul 2, 2026SMITH IAN FDirectorOption exercise3,440—Form 4
Apr 2, 2026SMITH IAN FDirectorOption exercise3,441—Form 4
Feb 18, 2026Howton David TChief Operating OfficerSale7,469$43.49KForm 4
Feb 18, 2026Tan KevinCFO & TreasurerSale5,404$31.47KForm 4
Feb 18, 2026Brooks GabrielChief Medical OfficerSale0—Form 4
Feb 18, 2026Herzich PaulChief Technology OfficerSale3,616$21.06KForm 4
Feb 18, 2026Ganot IlanDirectorSale2,658$15.48KForm 4
Feb 18, 2026Hanrahan JessieChief Regulatory OfficerSale4,134$24.07KForm 4
Feb 18, 2026Cumbo AlexanderPresident and CEOSale16,644$96.92KForm 4
Feb 13, 2026Howton David TChief Operating OfficerOption exercise14,687—Form 4
Feb 13, 2026Tan KevinCFO & TreasurerOption exercise10,625—Form 4
Feb 13, 2026Brooks GabrielChief Medical OfficerOption exercise10,937—Form 4
Feb 13, 2026Herzich PaulChief Technology OfficerOption exercise7,187—Form 4
Feb 13, 2026Ganot IlanDirectorOption exercise4,861—Form 4
Feb 13, 2026Hanrahan JessieChief Regulatory OfficerOption exercise8,125—Form 4
Feb 13, 2026Cumbo AlexanderPresident and CEOOption exercise30,031—Form 4
Feb 4, 2026Herzich PaulChief Technology OfficerSale10,905$70.25KForm 4
Feb 4, 2026Hanrahan JessieChief Regulatory OfficerSale12,348$79.54KForm 4
Feb 4, 2026Brooks GabrielChief Medical OfficerSale12,616$81.27KForm 4
Feb 4, 2026Ganot IlanDirectorSale7,205$46.41KForm 4
Feb 4, 2026Howton David TChief Operating OfficerSale18,894$121.71KForm 4
Feb 4, 2026Tan KevinCFO & TreasurerSale14,783$95.23KForm 4
Feb 4, 2026Cumbo AlexanderPresident and CEOSale48,913$315.09KForm 4
Feb 2, 2026Howton David TChief Operating OfficerSale37,771$243.13KForm 4
Feb 2, 2026Brooks GabrielChief Medical OfficerSale28,335$182.39KForm 4
Feb 2, 2026Hanrahan JessieChief Regulatory OfficerSale26,535$170.80KForm 4
Feb 2, 2026Herzich PaulChief Technology OfficerSale26,250$168.97KForm 4
Feb 2, 2026Cumbo AlexanderPresident and CEOSale80,258$516.61KForm 4
Feb 2, 2026Tan KevinCFO & TreasurerSale26,837$172.75KForm 4
Jan 31, 2026Howton David TChief Operating OfficerOption exercise42,275—Form 4
Jan 31, 2026Brooks GabrielChief Medical OfficerOption exercise28,225—Form 4
Jan 31, 2026Hanrahan JessieChief Regulatory OfficerOption exercise27,625—Form 4
Jan 31, 2026Ganot IlanDirectorOption exercise15,000—Form 4
Jan 31, 2026Herzich PaulChief Technology OfficerOption exercise24,675—Form 4
Jan 31, 2026Cumbo AlexanderPresident and CEOOption exercise100,400—Form 4
Jan 31, 2026Tan KevinCFO & TreasurerOption exercise33,075—Form 4
Jan 29, 2026Howton David TChief Operating OfficerOption exercise79,341—Form 4
Jan 29, 2026Brooks GabrielChief Medical OfficerOption exercise58,847—Form 4
Jan 29, 2026Hanrahan JessieChief Regulatory OfficerOption exercise54,925—Form 4
Jan 29, 2026Herzich PaulChief Technology OfficerOption exercise54,925—Form 4
Jan 29, 2026Cumbo AlexanderPresident and CEOOption exercise169,401—Form 4
Jan 29, 2026Tan KevinCFO & TreasurerOption exercise56,646—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related